|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash due from banks | ||||||||||||||||||||
| Federal funds sold and interest-bearing balances in banks | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Time deposits in banks | ||||||||||||||||||||
| Investment securities available-for-sale ("AFS"), at fair value, net of allowance for credit losses of $0 at both June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Equity securities, at fair value | ||||||||||||||||||||
| Federal Home Loan Bank ("FHLB") stock, at par | ||||||||||||||||||||
| Federal Reserve Bank ("FRB") stock, at par | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans, net of allowance for credit losses of $22,950 at June 30, 2026 and $21,210 at December 31, 2025 | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Other real estate owned ("OREO") | ||||||||||||||||||||
| Core deposit intangible, net | ||||||||||||||||||||
| Cash surrender value of bank owned life insurance ("BOLI") policies, net | ||||||||||||||||||||
| Right-of-use assets ("ROU"), net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Interest receivable and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Noninterest and interest bearing deposits | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Junior subordinated deferrable interest debentures, net | ||||||||||||||||||||
| Subordinated debt, net | ||||||||||||||||||||
| Salary continuation plan | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Interest payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' equity | ||||||||||||||||||||
| Common stock, no par value; 100,000,000 shares authorized; 10,909,317 and 10,887,681 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of tax | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
